Medicine and Dentistry
Clostridium Difficile Infection
64%
Peptoclostridium difficile
61%
Infection
38%
Prevalence
33%
Diarrhea
18%
Cohort Effect
18%
Clostridium
13%
Antibiogram
13%
Ribotyping
11%
Antiinfective Agent
10%
Recurrent Disease
10%
Vancomycin
10%
Clindamycin
10%
Pathogen
9%
Chemodynamic Therapy
9%
Diagnosis
9%
Moxifloxacin
8%
Genomic Epidemiology
8%
Fidaxomicin
8%
Metronidazole
8%
Antibiotic Resistance
7%
Hospital Inpatient
7%
Erythromycin
7%
Clavulanic Acid
7%
Amoxicillin
7%
Molecular Epidemiology
6%
Single Nucleotide Polymorphism
6%
Whole Genome Sequencing
6%
Evolution
6%
Tertiary Care
6%
Rifaximin
6%
Diseases
6%
Cystic Fibrosis
5%
Aboriginal Population
5%
Cross Sectional Study
5%
Emergency Department
5%
Gene Linkage
5%
Diagnosis of Clostridium Difficile
5%
Ridinilazole
5%
Serotype
5%
Antimicrobial Agent
5%
Odds Ratio
5%
Immunology and Microbiology
Peptoclostridium difficile
100%
Prevalence
33%
Whole Genome Sequencing
18%
Single Nucleotide Polymorphism
15%
Antibiotic Sensitivity
15%
Ribotyping
13%
Infectious Agent
9%
Antimicrobial Resistance
9%
Lineages
8%
Molecular Epidemiology
8%
Clostridium
7%
Genome Sequencing
5%
Dynamics
5%
Serotype
5%
Multidrug Resistance
5%
Evolution
5%
Pharmacology, Toxicology and Pharmaceutical Science
Peptoclostridium difficile
35%
Clostridium Difficile Infection
26%
Infection
13%
Prevalence
12%
Clostridium
11%
Antiinfective Agent
10%
Diarrhea
8%
Antimicrobial Resistance
5%
Ridinilazole
5%
Antibiotic Resistance
5%
Antimicrobial Agent
5%